Interval between prior SARS-CoV-2 infection and booster vaccination impacts magnitude and quality of antibody and B cell responses CM Buckner, L Kardava, O El Merhebi, SR Narpala, L Serebryannyy, ... Cell 185 (23), 4333-4346. e14, 2022 | 36 | 2022 |
Tracking B cell responses to the SARS-CoV-2 mRNA-1273 vaccine FL de Assis, KB Hoehn, X Zhang, L Kardava, CD Smith, O El Merhebi, ... Cell reports 42 (7), 2023 | 4 | 2023 |
Cost-Effective Modular Biosensor for SARS-CoV-2 and Influenza A Detection A Murray, J Ojeda, O El Merhebi, P Calvo-Marzal, Y Gerasimova, ... Biosensors 13 (9), 874, 2023 | 2 | 2023 |
Recent SARS-CoV-2 infection abrogates antibody and B-cell responses to booster vaccination CM Buckner, L Kardava, O El Merhebi, SR Narpala, L Serebryannyy, ... medRxiv, 2022 | 1 | 2022 |
Recent SARS-CoV-2 infection abrogates antibody and B-cell responses to booster vaccination (preprint) C Buckner, L Kardava, O El Merhebi, S Narpala, L Serebryannyy, B Lin, ... | | 2022 |
Sequence-Independent Assay for HIV Viral Load Quantitation O El Merhebi | | 2021 |